(Q51093928)

English

Identification of CDCA1-derived long peptides bearing both CD4+ and CD8+ T-cell epitopes: CDCA1-specific CD4+ T-cell immunity in cancer patients.

scientific article published in January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Identification of CDCA1-derived long peptides bearing both CD4+ and CD8+ T-cell epitopes: CDCA1-specific CD4+ T-cell immunity in cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Hirotake Tsukamoto

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Yusuke Tomita

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Akira Yuno

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Satoru Senju

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Sachiko Yoshimura

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Ryuji Osawa

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Yasuhiro Kuroda

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Masatoshi Hirayama

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Atsushi Irie

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Akinobu Hamada

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Hirofumi Jono

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Koji Yoshida

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Takuya Tsunoda

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Hirotsugu Kohrogi

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Yoshihiro Yoshitake

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Yusuke Nakamura

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Masanori Shinohara

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Yasuharu Nishimura

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

language of work or name

0 references

publication date

1 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

134

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

352-366

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24734272%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Helping the CD8(+) T-cell response

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Cooperation between CD4+ and CD8+ T cells: when, where, and how.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Peptide binding predictions for HLA DR, DP and DQ molecules

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Peptides derived from human insulin-like growth factor-II mRNA binding protein 3 can induce human leukocyte antigen-A2-restricted cytotoxic T lymphocytes reactive to cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Characterization of self-glutamic acid decarboxylase 65-reactive CD4+ T-cell clones established from Japanese patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Identification of HLA-A2-restricted CTL epitopes of a novel tumour-associated antigen, KIF20A, overexpressed in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

West Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligands

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Identification of a novel human cancer/testis antigen, KM-HN-1, recognized by cellular and humoral immune responses

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Identification of HLA-A24-restricted novel T Cell epitope peptides derived from P-cadherin and kinesin family member 20A

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Evolution of Pacific/Asian populations inferred from HLA class II allele frequency distributions

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastases

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Determinant spreading and tumor responses after peptide-based cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Cytotoxic chemotherapy and CD4+ effector T cells: an emerging alliance for durable antitumor effects

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Cancer immunotherapy--revisited

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

HLA anchor optimization of the melan-A-HLA-A2 epitope within a long peptide is required for efficient cross-priming of human tumor-reactive T cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

T Cell Assays and MIATA: The Essential Minimum for Maximum Impact

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28376

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51093928&oldid=1237367367"